These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15146190)

  • 1. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.
    Mato S; Chevaleyre V; Robbe D; Pazos A; Castillo PE; Manzoni OJ
    Nat Neurosci; 2004 Jun; 7(6):585-6. PubMed ID: 15146190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.
    Robbe D; Kopf M; Remaury A; Bockaert J; Manzoni OJ
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8384-8. PubMed ID: 12060781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens.
    Robbe D; Alonso G; Manzoni OJ
    Ann N Y Acad Sci; 2003 Nov; 1003():212-25. PubMed ID: 14684448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mouse brain slice preparation of the hippocampo-accumbens pathway.
    Matthews RT; Coker O; Winder DG
    J Neurosci Methods; 2004 Aug; 137(1):49-60. PubMed ID: 15196826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associative short-term synaptic plasticity mediated by endocannabinoids.
    Brenowitz SD; Regehr WG
    Neuron; 2005 Feb; 45(3):419-31. PubMed ID: 15694328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
    Mackie K
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S19-23. PubMed ID: 16570100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid mediator endocannabinoids in modulating synaptic transmission].
    Hashimotodani Y; Tanimura A; Kano M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):105-9. PubMed ID: 21800700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic mechanisms of endocannabinoid-mediated long-term depression in the hippocampus.
    Lafourcade CA
    J Neurophysiol; 2009 Oct; 102(4):2009-12. PubMed ID: 19553483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.
    Zlebnik NE; Cheer JF
    J Neurosci; 2016 Oct; 36(40):10230-10238. PubMed ID: 27707960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens.
    Fourgeaud L; Mato S; Bouchet D; Hémar A; Worley PF; Manzoni OJ
    J Neurosci; 2004 Aug; 24(31):6939-45. PubMed ID: 15295029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol.
    Butovsky E; Juknat A; Goncharov I; Elbaz J; Eilam R; Zangen A; Vogel Z
    J Neurochem; 2005 May; 93(4):802-11. PubMed ID: 15857384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C; Valentini V; Di Chiara G
    J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids: losing inhibition to increase learning capacity?
    Fitzjohn SM; Collingridge GL
    Neuron; 2004 Sep; 43(6):762-4. PubMed ID: 15363388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of endocannabinoid control of synaptic plasticity.
    Winters BL; Vaughan CW
    Neuropharmacology; 2021 Oct; 197():108736. PubMed ID: 34343612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute ethanol treatment prevents endocannabinoid-mediated long-lasting disinhibition of striatal output.
    Clarke RB; Adermark L
    Neuropharmacology; 2010; 58(4-5):799-805. PubMed ID: 20026138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ganglioside on synaptic plasticity of hippocampus in lead-exposed rats in vivo.
    She JQ; Wang M; Zhu DM; Sun LG; Ruan DY
    Brain Res; 2005 Oct; 1060(1-2):162-9. PubMed ID: 16229825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
    Kolb B; Gorny G; Limebeer CL; Parker LA
    Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.